Cargando…

Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography

BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular...

Descripción completa

Detalles Bibliográficos
Autores principales: Torkashvand, Ali, Riazi-Esfahani, Hamid, Ghassemi, Fariba, Khalili Pour, Elias, Masoomian, Babak, Zarei, Mohammad, Fadakar, Kaveh, Arjmand, Mojtaba, Tayebi, Fereshteh, Ekradi, Leila, Abrishami Moghaddam, Hamid, Mahmoudi, Tahereh, Daneshmand, Reihaneh, Faghihi, Hooshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562000/
https://www.ncbi.nlm.nih.gov/pubmed/34727878
http://dx.doi.org/10.1186/s12886-021-02140-w
_version_ 1784593181449388032
author Torkashvand, Ali
Riazi-Esfahani, Hamid
Ghassemi, Fariba
Khalili Pour, Elias
Masoomian, Babak
Zarei, Mohammad
Fadakar, Kaveh
Arjmand, Mojtaba
Tayebi, Fereshteh
Ekradi, Leila
Abrishami Moghaddam, Hamid
Mahmoudi, Tahereh
Daneshmand, Reihaneh
Faghihi, Hooshang
author_facet Torkashvand, Ali
Riazi-Esfahani, Hamid
Ghassemi, Fariba
Khalili Pour, Elias
Masoomian, Babak
Zarei, Mohammad
Fadakar, Kaveh
Arjmand, Mojtaba
Tayebi, Fereshteh
Ekradi, Leila
Abrishami Moghaddam, Hamid
Mahmoudi, Tahereh
Daneshmand, Reihaneh
Faghihi, Hooshang
author_sort Torkashvand, Ali
collection PubMed
description BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 ((106)Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. RESULTS: Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm(2) vs. 428 μm(2), P = 0.005; 1837 μm(2) vs 268 μm(2), P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. CONCLUSION: The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after (106)Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients.
format Online
Article
Text
id pubmed-8562000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85620002021-11-03 Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography Torkashvand, Ali Riazi-Esfahani, Hamid Ghassemi, Fariba Khalili Pour, Elias Masoomian, Babak Zarei, Mohammad Fadakar, Kaveh Arjmand, Mojtaba Tayebi, Fereshteh Ekradi, Leila Abrishami Moghaddam, Hamid Mahmoudi, Tahereh Daneshmand, Reihaneh Faghihi, Hooshang BMC Ophthalmol Research BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 ((106)Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. RESULTS: Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm(2) vs. 428 μm(2), P = 0.005; 1837 μm(2) vs 268 μm(2), P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. CONCLUSION: The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after (106)Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients. BioMed Central 2021-11-02 /pmc/articles/PMC8562000/ /pubmed/34727878 http://dx.doi.org/10.1186/s12886-021-02140-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Torkashvand, Ali
Riazi-Esfahani, Hamid
Ghassemi, Fariba
Khalili Pour, Elias
Masoomian, Babak
Zarei, Mohammad
Fadakar, Kaveh
Arjmand, Mojtaba
Tayebi, Fereshteh
Ekradi, Leila
Abrishami Moghaddam, Hamid
Mahmoudi, Tahereh
Daneshmand, Reihaneh
Faghihi, Hooshang
Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_full Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_fullStr Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_full_unstemmed Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_short Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_sort evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562000/
https://www.ncbi.nlm.nih.gov/pubmed/34727878
http://dx.doi.org/10.1186/s12886-021-02140-w
work_keys_str_mv AT torkashvandali evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT riaziesfahanihamid evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT ghassemifariba evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT khalilipourelias evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT masoomianbabak evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT zareimohammad evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT fadakarkaveh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT arjmandmojtaba evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT tayebifereshteh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT ekradileila evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT abrishamimoghaddamhamid evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT mahmouditahereh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT daneshmandreihaneh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT faghihihooshang evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography